N2-carboxyethyl-2′-deoxyguanosine, a DNA glycation marker, in kidneys and aortas of diabetic and uremic patients

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study

Patrick Maisonneuve, Lawrence Y. Agodoa, Ryszard Gellert et al. · The Lancet · 1999 · 879 citations

Medicine, Nephrology, Oncology +14

Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease

Nozomu Tanji, Glen S. Markowitz, Caifeng Fu et al. · Journal of the American Society of Nephrology · 2000 · 482 citations

Medicine, Nephrology, Pathobiology +17

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression.

Richard Bucala, Peter Model, Anthony Cerami · Proceedings of the National Academy of Sciences · 1984 · 210 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki et al. · Journal of Clinical Investigation · 1997 · 192 citations · Full text

Medicine, Biochemistry, Endocrinology +14

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein

Martin Busch, Sybille Franke, Andreas Müller et al. · Kidney International · 2004 · 119 citations · Full text

Medicine, Nephrology, Aging +9